Allison Clemens
April
ababaabhay
achoi2392
adhoward1

2025 PACUPrep BCCCP Preparatory Course Asthma Exacerbation Assessment of Severity and ABG Interpretation in Acute Asthma Exacerbations

Lesson 2, Topic 2

In Progress

← Previous

Assessment of Severity and ABG Interpretation in Acute Asthma Exacerbations

Lesson Progress

0% Complete

Objective Assessment and ABG Interpretation in Acute Asthma Severity Classification

Learning Objective

Apply diagnostic and classification criteria to assess the severity of an asthma exacerbation and guide immediate management.

Key Learning Points

Use objective measures (PEF, FEV₁, SpO₂) plus clinical findings (speech pattern, accessory muscle use, mental status) to stratify exacerbation severity.
Recognize that a normalizing or rising PaCO₂ in the face of persistent tachypnea and acidosis signals respiratory muscle fatigue and impending ventilatory failure.

1. Introduction

Summary: Rapid, accurate classification of asthma exacerbations is essential to guide therapy, allocate resources, and prevent progression to respiratory failure.

Early stratification informs urgency of bronchodilator delivery, corticosteroid administration, and need for advanced support.
Delayed recognition of severe or life-threatening exacerbations increases intubation rates and mortality.

Key Pearl

A systematic approach combining objective and clinical criteria reduces ICU admissions and need for intubation.

Challenges & Controversies

PEF/FEV₁ variability from patient effort, technique, and baseline lung function.
No universal ABG cutoff for intubation; clinical context and trajectory drive decisions.
A “normal” PaCO₂ in a tachypneic patient is ominous, not reassuring.

2. Objective Pulmonary Function Assessment

Summary: Quantitative lung function metrics provide rapid severity categorization but require proper technique and interpretation.

A. Peak Expiratory Flow (PEF)

Technique: Coach maximal inspiration and forceful exhalation into a calibrated meter; obtain three reproducible efforts.

Severity thresholds (percent predicted or personal best):

PEF Severity Thresholds
Severity	PEF (% predicted or personal best)
Mild	>70%
Moderate	40–69%
Severe	<40%
Life-threatening	<25%

Limitations: Effort-dependent; baseline variability; infeasible if fatigued.

Clinical Pearl

Serial PEF trends correlate better with clinical course than single measurements.

B. Forced Expiratory Volume in 1 Second (FEV₁)

Gold standard via spirometry; mirrors PEF thresholds.
In intubated patients, in-line ventilator sensors may estimate FEV₁.
Feasibility decreases with severe dyspnea or poor cooperation.

C. Oxygen Saturation (SpO₂)

Continuous pulse oximetry; SpO₂ <90% indicates severe hypoxemia.
In children, SpO₂ <92% predicts hospital admission.
Pitfalls: Motion artifact, poor perfusion, skin pigmentation bias.

Clinical Pearl

Always interpret SpO₂ in conjunction with clinical signs, especially in patients with dark skin tones.

3. Clinical Examination Findings

Summary: Physical signs rapidly reflect work of breathing and gas exchange impairment when objective data are limited.

A. Speech Patterns

Full sentences: Mild obstruction.
Phrases: Moderate severity.
Single words: Severe airflow limitation and muscle fatigue.

B. Accessory Muscle Use & Retractions

Observe sternocleidomastoid and intercostal retractions. This indicates increased work of breathing and imminent fatigue.

C. Mental Status Changes

Early agitation/confusion: May indicate hypercapnia.
Somnolence or decreased responsiveness: Suggests ventilatory failure.

Key Pearl

Altered mental status is a late, ominous sign requiring immediate escalation.

4. Arterial Blood Gas (ABG) Interpretation

Summary: ABGs assess ventilation and acid–base status; a rising PaCO₂ despite tachypnea signals decompensation.

A. Typical ABG Pattern in Acute Asthma

Early hyperventilation leads to respiratory alkalosis: low PaCO₂, elevated pH.

B. Ominous ABG Findings

“Normalizing” or rising PaCO₂ with persistent tachypnea.
Respiratory acidosis: pH <7.35 with PaCO₂ >45 mmHg.
Worsening hypoxemia may co-occur.

Clinical Pearl

A “normal” PaCO₂ in a distressed asthmatic is never benign—it reflects muscle fatigue and impending failure.

C. Pathophysiologic Correlation

Dynamic hyperinflation and air trapping impair alveolar ventilation.
V/Q mismatch worsens hypoxemia.
Respiratory muscle fatigue reduces CO₂ clearance.

D. Decision Thresholds for Escalation

Consider noninvasive ventilation if PaCO₂ is rising (<60 mmHg), patient is cooperative, and no contraindications.
Intubation indicated for PaCO₂ >50 mmHg with pH drop, altered mental status, exhaustion, or rapid deterioration.

Key Pearl

ABG trends must be integrated with clinical assessment—no single value dictates intubation.

5. Integrating Data into Severity Classification

Summary: Combine objective and clinical metrics into four categories—mild, moderate, severe, life-threatening—to guide interventions.

A. Classification Categories

Asthma Exacerbation Severity Classification
Severity Category	PEF/FEV₁ (% predicted)	SpO₂ (Room Air)	Clinical Signs
Mild	>70%	≥94%	Speaks in sentences, minimal/no accessory muscle use.
Moderate	40–69%	90–93%	Speaks in phrases, some accessory muscle use.
Severe	<40%	<90%	Single-word speech, marked accessory muscle use, possible agitation.
Life-threatening	<25%	<88% (or cyanosis)	Silent chest, altered mental status, exhaustion, rising/normal PaCO₂.

B. Algorithmic Approach

Rapid Assessment

(PEF/FEV₁, SpO₂, ABG if severe, Speech, Accessory Use, Mental Status)

Assign Severity Category

(Mild, Moderate, Severe, Life-threatening)

Initiate / Escalate Therapy

(Inhaled SABA ± Ipratropium, Systemic Corticosteroids, O₂, NIPPV/Intubation)

Repeat Assessment

(q 1-2 hours or as needed); Adjust Plan

Figure 1: Algorithmic Approach to Asthma Severity Assessment. This systematic process ensures timely and appropriate management based on integrated clinical and objective data.

Key Pearl

Trends in severity parameters are more informative than isolated readings.

6. Clinical Application and Pearls

Summary: Awareness of common pitfalls and adherence to best practices ensures timely, evidence-based escalation.

A. Common Pitfalls

Overreliance on a single metric (e.g., PEF alone).
Delayed ABG sampling missing window for NIPPV.
Underappreciation of SpO₂ bias in dark-skinned patients.
Ignoring subtle changes in speech or mental status.

B. Best Practices

Educate and coach on PEF technique; calibrate meters regularly.
Coordinate ABG timing with clinical changes.
Use standardized severity scoring tools; involve respiratory therapists early.
Document classification and communicate with the multidisciplinary team.

Clinical Pearl

Critical care pharmacists can lead severity-assessment protocols, ensuring rapid, standardized escalation and optimal outcomes.

Case Vignette (Board Prep)

A 42-year-old asthmatic presents with PEF 30% predicted, SpO₂ 89% on room air, speaking single words, and ABG shows PaCO₂ 48 mmHg, pH 7.33.

Classification: Severe exacerbation with early decompensation (respiratory acidosis and hypercapnia despite severe airflow obstruction).

Action: Escalate to ICU level care, continue aggressive nebulized short-acting beta-agonists (SABA) and ipratropium, administer IV corticosteroids. Prepare for potential non-invasive positive pressure ventilation (NIPPV) or intubation if no rapid improvement or further deterioration.

References

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2025. Available from: www.ginasthma.org
Nowak RM, Tomlanovich MC, Sarkar DD, Kvale PA, Anderson JA. Arterial blood gases and pulmonary function testing in acute bronchial asthma. Predicting patient outcomes. JAMA. 1983;249(15):2043–2046.
Geelhoed GC, Landau LI, Le Souëf PN. Evaluation of SaO₂ as a predictor of outcome in 280 children presenting with acute asthma. Ann Emerg Med. 1994;23(6):1236–1241.
Chan-Yeung M, Chang JH, Manfreda J, Ferguson A, Becker A. Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med. 1996;154(4 Pt 1):889–893.
Crooks CJ, West J, Card TR, Smith CJP, Navaratnam V. Pulse oximeter measurements vary across ethnic groups. Eur Respir J. 2022;59(4):2103246.
Rojas-Camayo J, Soria-Jara C, Luks AM, Checkley W, León-Velarde F. Reference values for oxygen saturation from sea level to the highest human habitation in the Andes. Thorax. 2018;73(8):776–778.
Soroksky A, Stav D, Shpirer I. Noninvasive positive pressure ventilation in acute asthmatic attack. Eur Respir Rev. 2010;19:39–45.
Leatherman J. Mechanical ventilation for severe asthma. Chest. 2015;147:1671–1680.
Feihl F, Perret C. Permissive hypercapnia. Am J Respir Crit Care Med. 1994;150:1722–1737.
McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med. 2003;168:740–759.

2025 PACUPrep BCCCP Preparatory Course

Pulmonary

Participants 432

Assessment of Severity and ABG Interpretation in Acute Asthma Exacerbations

Learning Objective

Key Learning Points

1. Introduction

2. Objective Pulmonary Function Assessment

A. Peak Expiratory Flow (PEF)

Severity thresholds (percent predicted or personal best):

B. Forced Expiratory Volume in 1 Second (FEV₁)

C. Oxygen Saturation (SpO₂)

3. Clinical Examination Findings

A. Speech Patterns

B. Accessory Muscle Use & Retractions

C. Mental Status Changes

4. Arterial Blood Gas (ABG) Interpretation

A. Typical ABG Pattern in Acute Asthma

B. Ominous ABG Findings

C. Pathophysiologic Correlation

D. Decision Thresholds for Escalation

5. Integrating Data into Severity Classification

A. Classification Categories

B. Algorithmic Approach

Rapid Assessment

Assign Severity Category

Initiate / Escalate Therapy

Repeat Assessment

6. Clinical Application and Pearls

A. Common Pitfalls

B. Best Practices

Case Vignette (Board Prep)

References